Serendipitous oxidation product of BIBN4096BS: A potent CGRP receptor antagonist

An oxidation product (5) formed during the synthesis of BIBN-4096BS (1) was found to be a potent CGRP antagonist (IC₅₀ = 0.11 nM). While 5 was found to be ten-fold less potent than 1, another analog 8 with lower molecular weight containing the oxidized fragment demonstrated twenty-fold higher activity than its parent 7. Alternative conditions which preclude the formation of the oxidation product are described. The activities of 1, 5, 7 and 8 in functional cAMP assay are also discussed.     

人降钙素基因相关肽转基因马铃薯的RT-PCR分析

报道经过农杆菌介导将人降钙素基因相关肽(calcitoningenerelatedpeptide,CGRP)基因由马铃薯块茎专一表达classIpatatin基因5′侧翼区和CaMV35S启动子驱动构建的马铃薯表达载体导入马铃薯,PCR鉴定获得了转基因植株。RTPCR分析证实classIpatatin基因5′侧翼区驱动的CGRPmRNA在转基因马铃薯中的表达。研究结果在开发转基因马铃薯生物反应器表达医用多肽中具有重要意义。     

(E)-Alkenes as replacements of amide bonds: Development of novel and potent acyclic CGRP receptor antagonists

A new class of CGRP receptor antagonists was identified by replacing the central amide of a previously identified anilide lead structure with ethylene, ethane, or ethyne linkers. (E)-Alkenes as well as alkynes were found to preserve the proper bioactive conformation of the amides, necessary for efficient receptor binding. Further exploration resulted in several potent compounds against CGRP-R with low susceptibility to P-gp mediated efflux.     

降钙素基因相关肽参与运动诱导的心脏保护作用

目的：探讨降钙素基因相关肽（CGRP）在运动诱导的心脏保护中的作用和机制。方法：64只健康雄性SD大鼠随机分为4组（n=16）,经耐力训练和力竭运动后,观察心肌CGRP的分布与表达、血清心肌肌钙蛋白I（cTnI）、心肌缺血低氧改变、心肌NO、SOD、MDA的变化。结果：TG心肌CGRP免疫反应和SOD总活性较CG显著增强,TEG和EG组CGRP免疫反应减弱,SOD总活性降低,MDA增加,且EG组血清心肌肌钙蛋白I显著升高,心肌出现明显的缺血低氧改变,NO含量下降。结论：CGRP参与耐力训练诱导的心脏保护作用,与上调SOD活性、促进NO合成有关。     

Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract

Calcitonin gene-related peptide (CGRP) exerts its diverse effects on vasodilation, nociception, secretion, and motor function through a heterodimeric receptor comprising of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1). Despite the importance of CLR·RAMP1 in human disease, little is known about its distribution in the human gastrointestinal (GI) tract, where it participates in inflammation and pain. In this study, we determined that CLR and RAMP1 mRNAs are expressed in normal human stomach, ileum and colon by RT-PCR. We next characterized antibodies that we generated to rat CLR and RAMP1 in transfected HEK cells. Having characterized these antibodies in vitro, we then localized CLR-, RAMP1-, CGRP- and intermedin-immunoreactivity (IMD-IR) in various human GI segments. In the stomach, nerve bundles in the myenteric plexus and nerve fibers throughout the circular and longitudinal muscle had prominent CLR-IR. In the proximal colon and ileum, CLR was found in nerve varicosities of the myenteric plexus and surrounding submucosal neurons. Interestingly, CGRP expressing fibers did not co-localize, but were in close proximity to CLR. However, CLR and RAMP1, the two subunits of a functional CGRP receptor were clearly localized in myenteric plexus, where they may form functional cell-surface receptors. IMD, another member of calcitonin peptide family was also found in close proximity to CLR, and like CGRP, did not co-localize with either CLR or RAMP1 receptors. Thus, CGRP and IMD appear to be released locally, where they can mediate their effect on their receptors regulating diverse functions such as inflammation, pain and motility.     

Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure

Calcitonin gene-related peptide (CGRP) and adrenomedullin (ADM) are potent vasodilators in humans and improved myocardial ischemia is observed after CGRP administration. Receptors for CGRP and ADM were already identified in heart. Receptor activity-modifying proteins (RAMPs) determine the ligand specificity of the calcitonin receptor-like receptor (CRLR); co-expression of RAMP1 and CRLR results in a CGRP receptor, whereas the association of RAMP2 or RAMP3 with CRLR gives an ADM receptor. As CGRP and ADM may play a beneficial role in heart failure, we investigated whether the CGRP and ADM receptors are upregulated in chronic heart failure. We have used semi-quantitative RT-PCR and Western-blot analysis to detect and quantify the mRNA and the protein of RAMP1 and RAMP3 in both atria and ventricles of failing hearts 6 months after aortic banding in rats. Our results showed for the first time an up-regulation of RAMP1 and RAMP3 mRNAs and proteins in this model of cardiac failure. No change was observed in mRNAs coding for CRLR, RAMP2, RDC1 (canine orphan receptor), and ADM. The present results suggested after congestive heart failure in adult rats, an up-regulation of the CGRP receptor (by an increase in RAMP1 that is associated with CRLR) in atria and ventricles and of ADM receptor (by increased RAMP3 expression that is associated with CRLR) in atria. These findings support a functional role for CGRP and ADM receptors to compensate the chronic heart failure in rats.     

慢性牙周炎患者血清CGRP、PGE2、CCL20与牙周临床指标和Th17/Treg失衡的相关性分析

摘要 目的：探究慢性牙周炎患者血清降钙素基因相关肽（CGRP）、前列腺素E₂（PGE₂）、CC趋化因子配体20（CCL20）与牙周临床指标和辅助性T淋巴细胞17/调节性T淋巴细胞（Th17/Treg）失衡的相关性。方法：选取2020年5月-2022年5月海南省妇女儿童医学中心收治的91例慢性牙周炎患者,根据其严重程度分为轻度组（39例）、中度组（36例）、重度组（16例）,比较三组血清CGRP、PGE₂、CCL20、牙周临床指标[出血指数（BI）、探诊深度（PD）、附着丧失（AL）、菌斑指数（PLI）]、外周血Th17细胞比例、Treg细胞比例、Th17/Treg比值,采用Pearson相关分析血清CGRP、PGE₂、CCL20与牙周临床指标和Th17/Treg失衡的相关性。结果：与轻度组比较,中度组、重度组血清CGRP、Treg细胞比例显著降低（P＜0.05）,血清PGE₂、CCL20、BI、PD、PLI、AL、Th17细胞比例、Th17/Treg比值显著增高（P＜0.05）;与中度组比较,重度组血清CGRP、Treg细胞比例显著降低（P＜0.05）,血清PGE₂、CCL20、BI、PD、PLI、AL、Th17细胞比例、Th17/Treg比值显著增高（P＜0.05）。相关性结果提示,血清PGE₂、CCL20水平与BI、PD、PLI、AL、Th17细胞比例、Th17/Treg比值呈正相关（P＜0.05）,与Treg细胞比例呈负相关（P＜0.05）;血清CGRP水平与BI、PD、PLI、AL、Th17细胞比例、Th17/Treg比值呈负相关（P＜0.05）,与Treg细胞比例呈正相关（P＜0.05）。结论：慢性牙周炎患者血清CGRP、PGE₂、CCL20水平与疾病严重程度、牙周临床指标及Th17/Treg失衡显著相关,血清CGRP、PGE₂、CCL20可能通过影响Th17/Treg平衡参与慢性牙周炎的发生和发展。     

Ontogeny of substance P-, CGRP-, and VIP-containing nerve fibers in the amphibian carotid labyrinth of the bullfrog,Rana catesbeiana

Summary The ontogeny of substance P, CGRP (calcitonin gene-related peptide), and VIP (vasoactive intestinal polypeptide) containing nerve fibers in the carotid labyrinth of the bullfrog, Rana catesbeiana, was examined by the peroxidase-antiperoxidase method. The time of appearance of these three peptides was different for each. First, CGRP fibers appeared in the wall of the carotid arch and external carotid arteries, and in a thin septum between these two arteries at an early stage of larval development (stage III). At stage V, substance P immunoreactive fibers appeared, and VIP fibers were detected at the early metamorphic stage (stage XXII). Up to the completion of metamorphosis, the number of these fibers remained low. From 1 to 5 weeks after metamorphosis, substance P, CGRP, and VIP fibers increased in number to varying degrees. By 8 weeks after metamorphosis, the distribution and abundance of these fibers closely resembled those of the adults. Some CGRP and VIP immunoreactive glomus cells were found at the stages immediately before and after the completion of metamorphosis. These findings suggest that substance P, CGRP, and VIP fibers during larval development and metamorphosis may be nonfunctional, and start to participate in vascular regulation only after metamorphosis. The transient CGRP and VIP in some glomus cells may be important for the development of the labyrinth, or may take part in vascular regulation through the close apposition of the glomus and smooth muscle cells (g-s connection).